A prognostic cytogenetic scoring system to guide the adjuvant management of patients with atypical meningioma

Neuro-Oncology

Volumn 18, Issue 2, 2016, Pages 269-274

  Aizer, Ayal A ^a   Abedalthagafi, Malak ^a   Linda Bi, Wenya ^a   Horvath, Margaret C ^a   Arvold, Nils D ^a   Al Mefty, Ossama ^a   Lee, Eudocia Q ^a   Nayak, Lakshmi ^a   Rinne, Mikael L ^a   Norden, Andrew D ^a   Reardon, David A ^a   Wen, Patrick Y ^a   Ligon, Keith L ^a   Ligon, Azra H ^a   Beroukhim, Rameen ^a   Dunn, Ian F ^a   Santagata, Sandro ^a   Alexander, Brian M ^a  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

Author keywords

atypical; copy number; meningioma; recurrence; resected

Indexed keywords

ADULT; AGE DISTRIBUTION; ARTICLE; ATYPICAL MENINGIOMA; CANCER ADJUVANT THERAPY; CANCER GRADING; CANCER PROGNOSIS; CANCER RECURRENCE; CANCER RISK; CLINICAL ARTICLE; COHORT ANALYSIS; CONTROLLED STUDY; CYTOGENETIC SCORING SYSTEM; DISEASE ASSOCIATION; FEMALE; HUMAN; MALE; MENINGIOMA; MIDDLE AGED; OUTCOME ASSESSMENT; RISK ASSESSMENT; RISK FACTOR; SCORING SYSTEM; SEX DIFFERENCE; TUMOR LOCALIZATION; TUMOR VOLUME; ADJUVANT CHEMORADIOTHERAPY; ALGORITHM; CANCER STAGING; COMPARATIVE GENOMIC HYBRIDIZATION; COPY NUMBER VARIATION; FOLLOW UP; GENETICS; MENINGEAL NEOPLASMS; PATHOLOGY; PILOT STUDY; PROGNOSIS; SURVIVAL RATE; TUMOR RECURRENCE;

ALGORITHMS; CHEMORADIOTHERAPY, ADJUVANT; COHORT STUDIES; COMPARATIVE GENOMIC HYBRIDIZATION; DNA COPY NUMBER VARIATIONS; FEMALE; FOLLOW-UP STUDIES; HUMANS; MALE; MENINGEAL NEOPLASMS; MENINGIOMA; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; NEOPLASM STAGING; PILOT PROJECTS; PROGNOSIS; SURVIVAL RATE;

EID: 84960428999     PISSN: 15228517     EISSN: 15235866     Source Type: Journal    
DOI: 10.1093/neuonc/nov177     Document Type: Article

References (26)

1. Vernooij MW, Ikram MA, Tanghe HL, et al. Incidental findings on brain MRI in the general population. N Engl J Med. 2007;357(18): 1821-1828.
2. Ostrom QT, Gittleman H, Liao P, et al. CBTRUS statistical report: primary brain and central nervous system tumors diagnosed in the United States in 2007-2011. Neuro Oncol. 2014;16(Suppl 4): iv1-iv63.
3. Durand A, Labrousse F, Jouvet A, et al. WHO grade II and III meningiomas: a study of prognostic factors. J Neurooncol. 2009; 95(3):367-375.
4. Goldsmith BJ, Wara WM, Wilson CB, Larson DA. Postoperative irradiation for subtotally resected meningiomas. A retrospective analysis of 140 patients treated from 1967 to 1990. J Neurosurg. 1994;80(2):195-201.
5. Debus J,Wuendrich M, Pirzkall A, et al. High efficacy of fractionated stereotactic radiotherapy of large base-of-skull meningiomas: long-term results. J Clin Oncol. 2001;19(15):3547-3553.
6. Goyal LK, Suh JH, Mohan DS, et al. Local control and overall survival in atypical meningioma: a retrospective study. Int J Radiat Oncol Biol Phys. 2000;46(1):57-61.
7. Alexander BM, Ramkissoon S, Wen PY, et al. Combined whole genome copy number genotyping and multiplex somatic mutation profiling of FFPE brain tumor specimens for clinical diagnosis and trial selection. J Clin Oncol. 2013;31(Suppl):2030.
8. Craig JM, Vena N, Ramkissoon S, et al. DNA fragmentation simulation method (FSM) and fragment size matching improve aCGH performance of FFPE tissues. PLoS One. 2012;7(6):e38881.
9. Abedalthagafi MS, Merrill PH, Bi WL, et al. Angiomatous meningiomas have a distinct genetic profile with multiple chromosomal polysomies including polysomy of chromosome 5. Oncotarget. 2014;5(21):10596-10606.
10. Ramkissoon SH, Bi WL, Schumacher SE, et al. Clinical implementation of integrated whole-genome copy number and mutation profiling for glioblastoma. Neuro Oncol. 2015. Mar 9. pii: nov015 [Epub ahead of print].
11. Aizer AA, Arvold ND, Catalano P, et al. Adjuvant radiation therapy, local recurrence, and the need for salvage therapy in atypical meningioma. Neuro Oncol. 2014;16(11):1547-1553.
12. Backer-Grondahl T, Moen BH, Arnli MB, et al. Immunohistochemical characterization of brain-invasive meningiomas. Int J Clin Exp Pathol. 2014;7(10):7206-7219.
13. Louis DN, Ohgaki H, Wiestler OD, et al. The 2007 WHO classification of tumours of the central nervous system. Acta Neuropathol. 2007;114(2):97-109.
14. Weber RG, Bostrom J, Wolter M, et al. Analysis of genomic alterations in benign, atypical, and anaplastic meningiomas: toward a genetic model of meningioma progression. Proc Natl Acad Sci USA. 1997;94(26):14719-14724.
15. Aghi MK, Carter BS, Cosgrove GR, et al. Long-term recurrence rates of atypical meningiomas after gross total resection with or without postoperative adjuvant radiation. Neurosurgery. 2009; 64(1):56-60, discussion 60.
16. Chang EL,Wefel JS, Hess KR, et al. Neurocognition in patients with brain metastases treated with radiosurgery or radiosurgery plus whole-brain irradiation: a randomised controlled trial. Lancet Oncol. 2009;10(11):1037-1044.
17. Brown PD, Pugh S, Laack NN, et al. Memantine for the prevention of cognitive dysfunction in patients receiving whole-brain radiotherapy: a randomized, double-blind, placebo-controlled trial. Neuro Oncol. 2013;15(10):1429-1437.
18. Duffner PK, Krischer JP, Horowitz ME, et al. Second malignancies in young children with primary brain tumors following treatment with prolonged postoperative chemotherapy and delayed irradiation: a Pediatric Oncology Group study. Ann Neurol. 1998; 44(3):313-316.
19. Armstrong GT, Liu Q, Yasui Y, et al. Long-term outcomes among adult survivors of childhood central nervous system malignancies in the Childhood Cancer Survivor Study. J Natl Cancer Inst. 2009;101(13):946-958.
20. Galloway TJ, Indelicato DJ, Amdur RJ, et al. Analysis of dose at the site of second tumor formation after radiotherapy to the central nervous system. Int J Radiat Oncol Biol Phys. 2012; 82(1):90-94.
21. Bowers DC, Liu Y, Leisenring W, et al. Late-occurring stroke among long-term survivors of childhood leukemia and brain tumors: a report from the Childhood Cancer Survivor Study. J Clin Oncol. 2006;24(33):5277-5282.
22. Mueller S, Fullerton HJ, Stratton K, et al. Radiation, atherosclerotic risk factors, and stroke risk in survivors of pediatric cancer: a report from the Childhood Cancer Survivor Study. Int J Radiat Oncol Biol Phys. 2013;86(4):649-655.
23. Campen CJ, Kranick SM, Kasner SE, et al. Cranial irradiation increases risk of stroke in pediatric brain tumor survivors. Stroke. 2012;43(11):3035-3040.
24. Gabeau-Lacet D, Engler D, Gupta S, et al. Genomic profiling of atypical meningiomas associates gain of 1q with poor clinical outcome. J Neuropathol Exp Neurol. 2009;68(10): 1155-1165.
25. Perry A, Banerjee R, Lohse CM, et al. A role for chromosome 9p21 deletions in the malignant progression of meningiomas and the prognosis of anaplastic meningiomas. Brain Pathol. 2002;12(2): 183-190.
26. Ruiz J, Martnez A, Hernández S, et al. Clinicopathological variables, immunophenotype, chromosome 1p36 loss and tumour recurrence of 247 meningiomas grade I and II. Histol Histopathol. 2010;25(3):341-349.